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Abstract
Objectives—Casual review of existing literature reveals a multitude of individualized
approaches to emergency department (ED) HIV testing. Cataloging the operational options of each
approach could assist translation by disseminating existing knowledge, endorsing variability as a
means to address testing barriers, and laying a foundation for future work in the area of
operational models and outcomes investigation. The objective of this study is to provide a detailed
account of the various models and operational constructs that have been described for performing
HIV testing in EDs.
Methods—Systematic review of PUBMED, EMBASE, the Cumulative Index to Nursing and
Allied Health Literature (CINAHL), and the Web of Science through February 6, 2009 was
performed. Three investigators independently reviewed all potential abstracts and identified all
studies that met the following criteria for inclusion: original research, performance of HIV testing
in an ED in the United States, description of operational methods, and reporting of specific testing
outcomes. Each study was independently assessed and data from each were abstracted with
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standardized instruments. Summary and pooled descriptive statistics were reported by using
recently published nomenclature and definitions for ED HIV testing.
Results—The primary search yielded 947 potential studies, of which 25 (3%) were included in
the final analysis. Of the 25 included studies, 13 (52%) reported results using nontargeted
screening as the only patient selection method. Most programs reported using voluntary, opt-in
consent and separate, signed consent forms. A variety of assays and communication methods were
used, but relatively limited outcomes data were reported.
Conclusion—Currently, limited evidence exists to inform HIV testing practices in EDs. There
appears to be recent progression toward the use of rapid assays and nontargeted patient selection
methods, with the rate at which reports are published in the peer-reviewed literature increasing.
Additional research will be required, including controlled clinical trials, more structured program
evaluation, and a focus on an expanded profile of outcome measures, to further improve our
understanding of which HIV testing methods are most effective in the ED.
Introduction
Background
Approximately 230,000 people in the United States have an undiagnosed HIV infection, and
it is estimated that 56,300 become newly infected each year.1,2 An important approach to
prevention of HIV infection includes early identification of existing disease. Much of the
effort directed toward earlier diagnosis has focused on expanding HIV testing in emergency
departments (EDs) because they are thought to serve as important clinical venues to perform
these activities.3,4
Importance
Testing for HIV infection in EDs has been categorized into the following distinct and
mutually exclusive testing approaches: diagnostic testing, targeted screening, and
nontargeted screening.3 Our understanding of ED HIV testing has been advanced by the
many investigators who have reported data from various practice models. Unfortunately,
relatively little is known about which method or methods are most feasible or effective in
this unique clinical setting or the relative ways in which testing may affect other ED
processes of care.
Goals of This Investigation
The objective of this study was therefore to provide a detailed account of the various
methods and operational constructs that have been described for performing HIV testing in
EDs as the initial step to allowing comparisons between approaches.
Methods
This project included only aggregate data from previously published work. As such, no
institutional review board approval was necessary. The reporting of this systematic review
was prepared in accordance with the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses statement.5
Search Strategy
To identify previous publications related to performing HIV testing in EDs, we performed
systematic searches of several publication search engines, including PubMed (MEDLINE),
EMBASE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and
the Web of Science. To identify all ED-related HIV testing publications from the beginning
of each database to the present, we used the following search criteria: “hiv” or “human
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immunodeficiency virus,” and “diagnosis,” “testing” or “screening,” and “emergency
department,” “emergency room,” “emergency ward,” or “emergency medical services.” In
addition, all participants of the 2007 National Emergency Department HIV Testing
Consortium consensus conference were individually searched by name to identify any other
published work.
Inclusion Criteria
We considered publications eligible for review if they included original research,
performance of HIV testing in an ED in the United States, description of operational
methods, and reporting of specific testing outcomes.
Publication Selection
All titles and abstracts from identified publications were screened in a blinded fashion for
eligibility by 3 independent reviewers (J.S.H., D.A.E.W., and M.S.L.). All publications
considered potentially relevant were retained and the full articles were reviewed for
inclusion. Of the full articles selected for inclusion, all references were also manually
searched to ensure inclusion of all relevant publications.
Assessment of Quality
The validity of study designs included in this synthesis was not formally assessed because of
the variety of designs and because most were primarily descriptive.
Data Extraction and Synthesis
Four reviewers (J.S.H., D.A.E.W., M.S.L., and R.E.R.) independently abstracted data in
duplicate from each article, using a structured data collection instrument. The data collection
instrument included sections related to the 4 “Core Theoretical Constructs” related to the
reporting of HIV testing activities in EDs, as reported in Lyons et al6 in 2008. These
constructs included (1) setting (geography and epidemiology, facility, and HIV testing
program); (2) recruitment and consent (patient selection strategies and criteria, HIV consent,
default assumption of patient willingness to undergo testing, patient awareness of right not
to undergo testing, patient identification of willingness to be tested, and integration with
consent process for general medical care); (3) postconsent program methods (testing and
assay, preresult communication, and postresult communication and methods); and (4)
outcomes. Outcomes included total number of eligible patients, total number offered HIV
testing, total number who received HIV testing, total confirmed positive results, total
number of patients linked to care, and mean or median CD4 counts for those who received a
confirmed positive result.
Data Management and Statistical Analyses
All data were entered into an electronic database (Microsoft Access; Microsoft, Redmond,
WA) and transferred into SAS format with translational software (df/Power DBMS/Copy;
DataFlux, Cary, NC). All analyses were performed with SAS version 9.2 (SAS Institute,
Inc., Cary, NC). All data were cleaned, and discrepancies identified during the dual
abstraction were resolved with an adjudication process that involved reabstraction of the
discrepant variables by another investigator (E.H.). Descriptive statistics are reported for all
variables. Continuous data are reported as medians with interquartile ranges (IQRs) and
categorical data are reported as percentages with 95% confidence intervals.
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The primary search yielded 947 unique publications. Of these, 55 (6%) were identified for
further evaluation after abstract screening. Of the 55 articles, 25 (46%) met criteria for
inclusion after complete review and represent the sample used for this synthesis (Figure).
All included publications ranged from 1992 through 2009.7-31
Of the 25 included publications, 12 (48%) resulted from the Northeast, 5 (20%) from the
Midwest, 5 (20%) from the West, and 3 (12%) from the South. Additionally, all 22 (100%)
of the publications that reported a setting were categorized as urban, and of the 13
publications that reported the type of institution, 12 (92%) described their institutions as
academic or teaching, and only 1 (8%) publication reported its institution as community
based. Of the 19 institutions that reported annual ED census data, the median census was
55,000 patient visits (IQR 44,000 to 95,000 patient visits). Of the 13 publications that
reported funding to support their programs, all (100%) reported having received external
funding.
Of the 25 included publications, 1 (4%) reported performing diagnostic testing only, 2 (8%)
reported performing targeted screening only, 13 (52%) reported performing nontargeted
screening only, 8 (32%) reported performing a combination of testing methods, and 1 (4%)
did not report an explicit patient selection method.
Table 1 describes staffing and consent methods stratified by different HIV testing
approaches. Of the 23 publications that reported general consent methods, 22 (96%) used a
voluntary approach. Of the 21 publications that reported a distinction between using opt-in
versus opt-out approaches, 20 (95%) used an opt-in approach. Of the 15 publications that
reported using verbal or signed consent, all (100%) used signed consent, and of the 21
publications that reported using integrated or separate consent documentation, 20 (95%)
used separate documentation. Last, of the 13 publications that reported solely performing
nontargeted screening, only 1 (8%) used an opt-out approach.
Table 2 describes assay methods stratified by different HIV testing approaches. Of the 18
publications that reported using either blood or saliva, 11 (61%) used blood as the only
source of testing and all (100%) reported using venipuncture as the method of obtaining
blood. Of the 21 publications that reported using rapid or conventional assays, 10 (48%)
used rapid assays only, 7 (33%) used conventional assays only, and 2 (10%) used a
combination of the 2 assays. None of the publications reported using antigen-based or
nucleic acid–based testing. Of the 13 publications that reported the site of performing the
assay, 4 (31%) used an external laboratory, 3 (23%) performed the assay at the patient's
bedside, 2 (15%) used an ED-based laboratory, 2 (15%) used the hospital's laboratory, and 2
(15%) used a combination of these approaches.
Table 3 describes methods of preresult and postresult communication and linkage to care
stratified by different HIV testing approaches. Of the 20 publications that reported preresult
communication methods, 7 (35%) used prevention counseling, only 6 (30%) provided
information only, and 6 (30%) used a combination of the 2 methods. Similarly, of the 15
publications that reported postresult communication methods, 9 (60%) used prevention
counseling only, 2 (13%) provided information only, and 4 (27%) used a combination of the
2 methods. Additionally, of the 21 publications that reported when postresult
communication was provided, 12 (57%) provided it after ED discharge only, 7 (33%)
provided it during the ED visit only, and 2 (10%) reported providing a combination. All 12
publications that reported performing postresult communication after ED discharge also
performed conventional HIV testing. Furthermore, in-person communication and active
linkage to care were performed in the majority of programs.
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Table 4 describes the reported outcomes stratified by different HIV testing approaches.
Relative to the other 2 testing approaches (diagnostic testing and targeted screening),
nontargeted screening resulted in a larger number of patients being offered testing yet a
similar number of patients receiving a diagnosis of HIV infection.
Limitations
The results of this study are limited by the relatively small number of studies focused in
academic settings. As such, the ability to make comparisons and to determine effectiveness
of various approaches and operational methods was not possible, and therefore the results
are not easily generalizable to the thousands of community-based EDs in the United States.
Given the heterogeneous nature of the publications included, we were also not able to
combine studies in such a way as to make direct comparisons between operational methods
and outcomes.
The primary limitation of this project is inherent to the literature base reviewed. A finding of
our review was that publications to date may not, in the aggregate, be generalizable,
comprehensive, or fully interpretable. Beyond this, it is possible the synthesis was limited by
selection bias. Although we used a systematic approach to identification of publications, it is
possible 1 or more relevant articles were not included. Additionally, it is possible that
misclassification bias was introduced during the abstraction process, although our approach
was designed to minimize this possibility.
Discussion
This article represents work initiated during the 2007 Conference of the National Emergency
Department HIV Testing Consortium, held in Baltimore, MD, on November 12, 2007. To
our knowledge, this represents the first attempt to systematically synthesize operational
aspects of performing HIV testing in the ED. In doing so, we hope it will assist in translation
of HIV testing practices by disseminating existing knowledge, endorsing variability as a
means to address testing barriers, and laying a foundation for future investigations in the
area of operational models and outcomes.
Operational HIV Testing Models Not Fully Characterized
Overall, a relatively small number of programs were included in this synthesis and all but 1
resulted from an academic setting. In addition, the majority of publications included in this
study occurred after 2003 and most occurred after 2006, with all but 2 of the studies
representing observational research. As such, the overall generalizability of the findings is
relatively limited.
The performance of HIV testing in the ED has received substantial attention during the past
several years, and an acceleration of work in this area occurred after the release of the 2006
Centers for Disease Control and Prevention (CDC) recommendations for HIV testing in
health care settings.32,33 With a small but growing experience and relatively little
comparative evidence, investigators have primarily developed testing programs de novo.
After review of the articles, it became implicitly or explicitly apparent that most HIV testing
methods were developed or selected after consideration of specific testing barriers present
within a given practice setting. Although these early studies provided new insights about
HIV testing practices, as the evidence base grows, it is increasingly likely that new programs
will adopt testing methods from previously reported work, rather than independently
designing novel methods in response to individualized practice circumstances.
Haukoos et al. Page 5













Of the 25 reported studies, only 1 reported and detailed performing exclusively diagnostic
testing and only 2 reported and detailed performing exclusively targeted screening.
Although emphasis on nontargeted screening has occurred during the past several years in
response primarily to the current CDC recommendations, the former 2 testing strategies
remain important and relatively unevaluated in the ED setting. In fact, some have advocated
that diagnostic testing serve as the minimum HIV testing standard of care in the ED, but
given the relatively few studies, others may view this contention as uncertain.34
Additionally, targeted screening remains relatively unevaluated in the ED setting. Given that
nontargeted screening in the ED is relatively resource intensive, targeted screening may
serve as a more effective approach. Comparative clinical trials of targeted screening versus
nontargeted screening have not been performed to date, and unfortunately, little is known
about how best to target patients in this unique clinical setting.9,10
Individual Operational Details Within HIV Testing Models
Using a template adopted from Lyons et al6 for the reporting of HIV testing programs, we
found that a relatively large proportion of individual studies lacked relevant details about
operational methods used, making it difficult to make meaningful comparisons between
different testing approaches or within approaches that use the same patient selection
strategies. This relative lack of information highlights the need to improve our
understanding of which testing methods are most effective in the emergency care setting and
suggests the need for more structured research, including the performance of prospective
controlled clinical trials.
Nearly all testing programs used a voluntary, opt-in consent approach with separate signed
consent forms. The current recommendation by the CDC, to use an opt-out approach and to
integrate consent into the general consent process in the ED, has not yet been widely
studied. Although several studies are being conducted and will likely inform our practices
relative to obtaining consent for HIV testing, none were included in this synthesis.
Therefore, the optimal approach to obtaining consent remains uncertain, especially in the
context of patient understanding and acceptance and the process by which consent is
obtained in the ED.
A variety of HIV testing and communication approaches were also reported by studies
included in this review, including both rapid and conventional testing. With the introduction
of highly accurate rapid assays, conventional testing now appears to be less common. The
ED environment, including its acute episodic nature and relative lack of structured follow-
up, lends itself more to using rapid assays as the primary means of performing HIV testing.
Additionally, most communication methods included prevention counseling, consistent with
HIV testing recommendations before 2006. As attempts have been made to mitigate barriers
particular to performing HIV testing in EDs, use of pretest information or educational videos
and limited postresult counseling has been emphasized. Although Calderon et al19,24,35 and
Merchant et al31 have published work related to use of educational videos in the setting of
ED-based HIV testing, relatively little additional research has been published that describes
how best to integrate these aspects into operational models.
A variety of staffing approaches were reported, although a large proportion of models used
external staff to perform HIV testing in the ED. The ability to integrate HIV testing into EDs
using native or external staff will likely depend heavily on how testing is funded. Although
most testing models have been developed and evaluated in academic settings, it is clear that
to integrate HIV testing and screening into community-based EDs, use of native staff will be
required. As such, additional research and experience with using native staff to implement
different testing models will be needed.
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This synthesis highlights the need for future controlled clinical trials and more rigorous
comparative effectiveness and program evaluation studies to determine which unique
operational methods are most effective and whether unique models of testing are most
effective and efficient relative to emergency medical care.
Future Directions
To facilitate the adoption of operational models described in the literature, there appear to be
2 primary unmet needs. First, the literature base needs to be more standardized and clarified.
In this systematic review, there were many instances in which it was questionable whether
terms used identically in different articles actually referred to precisely the same operational
practice. Recently published consensus standards for nomenclature and definitions should
assist in this effort, although a standardized approach to the reporting of operational methods
based on consensus-based reporting guidelines is still needed. Such consensus guidelines are
being developed in conjunction with the National ED HIV Testing Consortium. Second,
there is a need for improved understanding of which operational models are most effective.
This can be accomplished through comparative study of operational methods, within and
between settings, and through use of a standard set of outcomes.
Conclusion
Currently, limited evidence exists to inform HIV testing practices in EDs. There appears to
be recent progression toward the use of rapid assays and nontargeted patient selection
methods, with the rate at which reports are published in the peer-reviewed literature
increasing. Additional research including controlled clinical trials, more structured program
evaluation, and a focus on an expanded profile of outcome measures will be required to
further improve our understanding of which HIV testing methods are most effective in the
ED.
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Flow diagram of selection process of included articles.
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Table 1









Native 1 (100) 1 (50) 3 (23) 3 (38)
Exogenous 0 1 (50) 7 (54) 1 (12)
Combined 0 0 2 (15) 4 (50)
Not reported 0 0 1 (8) 0
Consent
Mandatory 0 0 0 1 (12)
Voluntary 1 (100) 2 (100) 13 (100) 6 (75)
Not reported 0 0 0 1 (12)
Opt in 1 (100) 2 (100) 12 (92) 5 (63)
Opt out 0 0 1 (8) 0
Not reported 0 0 0 3 (37)
Implicit 0 0 4 (31) 0
Explicit 1 (100) 0 3 (23) 0
Not reported 0 2 (100) 6 (46) 8 (100)
Verbal 0 0 0 0
Signed 1 (100) 2 (100) 7 (54) 5 (63)
Not reported 0 0 6 (46) 3 (37)
Integrated 0 0 0 1 (12)
Separate 1 (100) 2 (100) 12 (92) 5 (63)
Not reported 0 0 1 (8) 2 (25)
*
A total of 25 publications met criteria for inclusion in this systematic review. However, one did not report an explicit patient selection method and
therefore was not included in this table.
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Table 2








Blood only 1 (100) 2 (100) 3 (23) 5 (63)
Saliva only 0 0 3 (23) 2 (25)
Both 0 0 2 (15) 0
Not reported 0 0 5 (39) 1 (12)
Oral swab only 0 0 3 (23) 2 (25)
Fingerstick only 0 0 0 0
Venipuncture only 0 2 (100) 3 (23) 5 (63)
Combination 0 0 2 (15) 0
Not reported 1 (100) 0 5 (39) 1 (12)
Rapid only 1 (100) 0 7 (54) 2 (25)
Conventional only 0 2 (100) 2 (15) 5 (63)
Both 0 0 2 (15) 0
Not reported 0 0 2 (15) 1 (12)
Antibody 1 (100) 2 (100) 10 (77) 7 (88)
Antigen 0 0 0 0
Nucleic acid 0 0 0 0
Not reported 0 0 3 (23) 1 (12)
POC bedside only 0 0 3 (23) 0
POC ED only 0 0 1 (8) 1 (12)
Laboratory only 1 (100) 0 0 1 (12)
External lab only 0 0 2 (15) 2 (25)
Combination 0 0 1 (8) 1 (12)
Not reported 0 2 (100) 6 (46) 3 (38)
WB confirmation 1 (100) 1 (50) 10 (77) 8 (100)
Not reported 0 1 (50) 3 (23) 0
POC, Point of care; WB, Western blot.
*
A total of 25 publications met criteria for inclusion in the systematic review. However, one did not report an explicit patient selection method and
was therefore not included in this table.
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Table 3







Only (N=13) Combination (N=8)
Preresult communication
Information only 0 0 5 (38) 1 (12)
Education only 0 0 0 0
Counseling only 0 1 (50) 1 (8) 5 (63)
Combination 1 (100) 0 4 (31) 1 (12)
None 0 0 0 1 (12)
Not reported 0 1 (50) 3 (23) 0
Postresult communication n
Information only 0 0 2 (15) 0
Education only 0 0 0 0
Counseling only 0 2 (100) 4 (31) 3 (38)
Combination 1 (100) 0 2 (15) 1 (12)
None 0 0 0 0
Not reported 0 0 5 (38) 4 (50)
Physician only 0 0 0 0
Nurse only 0 0 0 0
Counselor only 0 0 1 (8) 3 (38)
Social worker only 0 0 0 0
Other 0 0 3 (23) 0
Combination 1 (100) 1 (50) 2 (15) 2 (25)
Not reported 0 1 (50) 7 (53) 3 (38)
In ED only 1 (100) 0 4 (31) 2 (25)
After discharge Only 0 2 (100) 4 (31) 6 (75)
Both 0 0 2 (15) 0
Not reported 0 0 3 (23) 0
In person only 1 (100) 0 9 (69) 5 (63)
By mail only 0 0 0 0
By telephone only 0 0 0 0
Other 0 0 0 0
Combination 0 1 (50) 1 (8) 1 (12)
Not reported 0 1 (50) 3 (23) 2 (25)
Linkage
Active only 1 (100) 1 (50) 4 (31) 4 (50)
Passive only 0 0 1 (8) 0
Both 0 0 1 (7) 0
Not reported 0 1 (50) 7 (54) 4 (50)
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*
A total of 25 publications met criteria for inclusion in the systematic review. However, one did not report an explicit patient selection method and
therefore was not included in this table.
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Table 4











Eligible patients 0 (0) 537 (200–873) 3,030 (2,155–13,240) 32,121 (5,285–118,324)
Offered HIV testing 0 (0) 200 (†) 3,030 (2,356–4,187) 1,287 (494–8,574)
Received HIV testing 681 (†) 177 (168–186) 1,438 (944–2,293) 860 (187–4,371)
Confirmed positive 15 (†) 24 (†) 9 (6–55) 15 (4–83)
Linked to care 12 (†) 6 (†) 19 (4–26) 22 (7–61)
CD4 count 0 (0) 0 (0) 503 (†) 0 (0)
*
A total of 25 publications met criteria for inclusion in this systematic review. However, one did not report an explicit patient selection method and
therefore was not included in this table.
†
Represents 1 study.
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